Aspirin Action in Endothelial Cells: Different Patterns of Response Between Chemokine CX3CL1/CX3CR1 and TNF-α/TNFR1 Signaling Pathways
Open Access
- 12 May 2015
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 29 (3) , 219-229
Abstract
Purpose TNF-α induces fractalkine (CX3CL1) and its receptor CX3CR1 in endothelial cells through NF-қB activation. NF-қB inhibitors may reduce the expression of CX3CL1, and modulation of the CX3CL1/CX3CR1 signaling was proposed as a new target for aspirin. We examined the effects of aspirin on CX3CL1 and TNF-α production, as well as CX3CR1 and TNFR1 expression. Methods HUVECs isolated after term pregnancies (N = 28) were cultured in vitro. Lipopolysaccharide (1 μg/ml) was used as CX3CL1 inducer. HUVECs were exposed to six different concentrations of aspirin (between 1.0 and 6.0 mM) during 7 days. The levels of CX3CL1 and TNF-α in the culture media were measured using ELISA. After termination of the cultures, mean expressions of CX3CR1 and TNFR1 were examined in the immunostained paraffin sections using quantitative immunohistochemistry. Results Aspirin significantly (p < 0.05) decreased CX3CL1 production, and the mean decrease in CX3CL1 production was inversely proportional to increased (p < 0.05) expression of CX3CR1. The combined mean CX3CL1 concentrations, including all time points, equaled 782.18 ± 74.4 pg/ml in aspirin treated HUVECs compared to a total concentration of 2467.53 ± 127.5 pg/ml combined from the respective time points in the controls. An inhibition of TNF-α production in HUVECs after pretreatment with aspirin was observed. Unlike in the case of CX3CR1 expression, there were no signs of TNFR1 upregulation. Conclusions Autoregulation between CX3CL1 and CX3CR1 may explain overexpression of CX3CR1 as the compensatory effect in aspirin-treated HUVECs. Inhibition of CX3CR1 could prevent thrombotic complications in the early period after discontinuation of aspirin.Keywords
This publication has 47 references indexed in Scilit:
- Neuron–glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stageOpen Biology, 2013
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1PLOS ONE, 2012
- Contribution of Platelet CX 3 CR1 to Platelet–Monocyte Complex Formation and Vascular Recruitment During HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Fractalkine/CX3CR1 and atherosclerosisClinica Chimica Acta, 2011
- Characterization of Synergistic Induction of CX3CL1/Fractalkine by TNF-α and IFN-γ in Vascular Endothelial Cells: An Essential Role for TNF-α in Post-Transcriptional Regulation of CX3CL1The Journal of Immunology, 2010
- Genistein Suppression of TNF-α-induced Fractalkine Expression in Endothelial CellsCellular Physiology and Biochemistry, 2010
- Aspirin Inhibits Fractalkine Expression in Atherosclerotic Plaques and Reduces Atherosclerosis in ApoE Gene Knockout MiceCardiovascular Drugs and Therapy, 2009
- Isolation of Human Umbilical Vein Endothelial Cells (HUVEC)Journal of Visualized Experiments, 2007
- Hepatitis C Virus Core Protein Potentiates TNF-α-Induced NF-κB Activation through TRAF2-IKKβ-Dependent PathwayBiochemical and Biophysical Research Communications, 2001